List
The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until April, 2020.
-
Accurate accessible cloud software for protein folding for molecular biologists
SBC: DNASTAR, INC. Topic: 100DESCRIPTION provided by applicant Most drugs interact with protein molecules to elicit a cellular response Traditional drug discovery is a laborious and expensive experimental process so computational approaches to assess protein function and to accelerate the discovery process are in high demand Virtual drug screening and structure based drug design represent computational approaches that c ...
SBIR Phase II 2015 Department of Health and Human Services -
Synthetic lubricin biomaterial for osteoarthritis
SBC: ARTICULATE BIOMEDICAL, LLC Topic: NIAMSDESCRIPTION provided by applicant Osteoarthritis OA is a significant contributor to human morbidity and mortality with an economic burden exceeding $ billion annually in the United States Lubricin is a natural lubricant of the articular cartilage of the knee and the intraarticular administration of lubricin prevents OA progression following knee injury However the manufacture of lubrici ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Restimulating memory T cell responses in elderly by a novel, live influenza vaccine
SBC: Flugen, Inc. Topic: NIAIDDESCRIPTION provided by applicant Respiratory infections with influenza viruses cause severe morbidity and mortality in humans and animals worldwide Importantly in humans the majority of morbidity and mortality following flu infection is seen in older individuals andgt year old Yet clear understanding of how aging impacts on innate immune responses and how to improve vaccine design ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
A new generation of targeted therapeutics for the treatment of cancer
SBC: NERX BIOSCIENCES, INC. Topic: NCIDESCRIPTION provided by applicant Development of novel lung cancer therapeutics targeting the DNA damage response Abstract Lung tissue is constantly exposed to a wide variety of inhaled chemical agents While the majority of these maybe innocuous those that damage DNA have severe consequences Thus the DNA damage response DDR and DNA repair in these tissues is extremely important The vast ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Prostate Cancer Assessment Via Integrated 3D ARFI Elasticity Imaging and Multi-Parametric MRI
SBC: Kitware, Inc. Topic: 102DESCRIPTION provided by applicant Prostate cancer PCA is the most common non skin cancer and the second leading cause of cancer death in American men with over new cases diagnosed and over PCA deaths annually in the United States Ultrasound guided biopsy is the standard of care for confirming cancer typically following elevated PSA levels however it has been estimated that ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Diagnosing aggressive prostate cancer by spectroscopic photoacoustic tomography
SBC: Vibronix Inc. Topic: 102DESCRIPTION provided by applicant Prostate cancer PCa is the No killer among male cancer patients The ultimate test is based on transrectal ultrasound guided needle biopsy and histological examination of fixed prostate tissues This conventional diagnostic procedure is invasive missing cases of cancer due to small sampling volume Moreover it leads to an overtreatment of patients du ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
A biochemical companion diagnostic platform to measure kinase inhibitor pharmacodynamics in leukemia
SBC: MICROFLUIDIC INNOVATIONS, LLC Topic: 102DESCRIPTION provided by applicant Kinase inhibitors created a new paradigm in chemotherapy and are a major focus of new oncology drug development The Bcr Abl inhibitor imatinib was a breakthrough drug for chronic myelogenous leukemia with overwhelming early results however at least of patients are either intolerant resistant or experience recurrence within years and individual respo ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
sxRNA-based Antiviral Approach targeting Epstein-Barr virus
SBC: HocusLocus Inc. Topic: NIAIDDESCRIPTION provided by applicant The goal of this Phase I is to develop a prototype for a novel antiviral therapy directed towards Epstein Barr virus based on a novel post transcriptional regulatory mechanism called structurally interacting RNA or sxRNA We are pioneering a revolutionary antiviral approach that uses a viral encoded microRNA miRNA to create specificity even in infections in t ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Real-Time Spliced-RNA Detection to Quantify Latent HIV-Infected Cells in HAART Patients
SBC: Jan Biotech, Inc. Topic: NIAIDDESCRIPTION provided by applicant The CDC estimates that in the U S people aged years and older are living with HIV infection with approximately others infected but undiagnosed CDC Strict adherence to highly active combination anti retroviral therapy HAART cART prevents full blown AIDS However HAART cART fails to cure HIV infection as it has little ...
STTR Phase I 2015 Department of Health and Human Services -
Spinal Pseudoarthrosis Mitigation Using Nano Devices
SBC: NANOVIS, LLC Topic: NIADESCRIPTION provided by applicant This project presents a novel strategy and technology platform to achieve durable spinal stabilization despite non fusion pseudoarthrosis The team proposes to develop novel nanotube enhanced micron porous interbody fusion devices IFDs and nanotube enhanced pedicle screws as fixation devices for spinal reconstruction The technology is expected to speed up a ...
SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health